Loading clinical trials...
Loading clinical trials...
The Effect of Primary Care Opioid Taper Plans and Their Components on Sustained Opioid Taper and Opioid Discontinuation
Conditions
Interventions
Taper Plan
Locations
1
United States
Kaiser Permanente Washington Health Research Institute
Seattle, Washington, United States
Start Date
January 1, 2018
Primary Completion Date
October 30, 2018
Completion Date
March 31, 2019
Last Updated
August 21, 2019
Lead Sponsor
Kaiser Permanente
Collaborators
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions